80 related articles for article (PubMed ID: 18086111)
1. Importance of biliary excretion of indomethacin in gastrointestinal and hepatic injury.
Dial EJ; Darling RL; Lichtenberger LM
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e384-9. PubMed ID: 18086111
[TBL] [Abstract][Full Text] [Related]
2. Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats.
Barrios JM; Lichtenberger LM
Gastroenterology; 2000 Jun; 118(6):1179-86. PubMed ID: 10833493
[TBL] [Abstract][Full Text] [Related]
3. In vitro evidence that phosphatidylcholine protects against indomethacin/bile acid-induced injury to cells.
Dial EJ; Dawson PA; Lichtenberger LM
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(3):G217-22. PubMed ID: 25477376
[TBL] [Abstract][Full Text] [Related]
4. Indomethacin enhances bile salt detergent activity: relevance for NSAIDs-induced gastrointestinal mucosal injury.
Petruzzelli M; Moschetta A; Renooij W; de Smet MB; Palasciano G; Portincasa P; van Erpecum KJ
Dig Dis Sci; 2006 Apr; 51(4):766-74. PubMed ID: 16615001
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic study of the hepatobiliary transport of indomethacin.
Kouzuki H; Suzuki H; Sugiyama Y
Pharm Res; 2000 Apr; 17(4):432-8. PubMed ID: 10870987
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin disrupts the protective effect of phosphatidylcholine against bile salt-induced ileal mucosa injury.
Venneman NG; Petruzzelli M; van Dijk JE; Verheem A; Akkermans LM; Kroese AB; van Erpecum KJ
Eur J Clin Invest; 2006 Feb; 36(2):105-12. PubMed ID: 16436092
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.
Lim YJ; Phan TM; Dial EJ; Graham DY; Lichtenberger LM
Digestion; 2012; 86(2):171-7. PubMed ID: 22907267
[TBL] [Abstract][Full Text] [Related]
8. Role of phosphatidylcholine saturation in preventing bile salt toxicity to gastrointestinal epithelia and membranes.
Dial EJ; Rooijakkers SH; Darling RL; Romero JJ; Lichtenberger LM
J Gastroenterol Hepatol; 2008 Mar; 23(3):430-6. PubMed ID: 17868333
[TBL] [Abstract][Full Text] [Related]
9. Aspirin's ability to induce intestinal injury in rats is dependent on bile and can be reversed if pre-associated with phosphatidylcholine.
Lichtenberger LM; Phan T; Okabe S
J Physiol Pharmacol; 2011 Aug; 62(4):491-6. PubMed ID: 22100851
[TBL] [Abstract][Full Text] [Related]
10. Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs.
Zhou Y; Dial EJ; Doyen R; Lichtenberger LM
Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G722-31. PubMed ID: 20203063
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin injury to the rat small intestine is dependent upon biliary secretion and is associated with overgrowth of enterococci.
Mayo SA; Song YK; Cruz MR; Phan TM; Singh KV; Garsin DA; Murray BE; Dial EJ; Lichtenberger LM
Physiol Rep; 2016 Mar; 4(6):. PubMed ID: 27033447
[TBL] [Abstract][Full Text] [Related]
12. Role of bile in pathogenesis of indomethacin-induced enteropathy.
Jacob M; Foster R; Sigthorsson G; Simpson R; Bjarnason I
Arch Toxicol; 2007 Apr; 81(4):291-8. PubMed ID: 17151867
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal safety and therapeutic efficacy of parenterally administered phosphatidylcholine-associated indomethacin in rodent model systems.
Lichtenberger L; Romero JJ; Dial EJ
Br J Pharmacol; 2009 May; 157(2):252-7. PubMed ID: 19366347
[TBL] [Abstract][Full Text] [Related]
15. Advent of novel phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety.
Lim YJ; Dial EJ; Lichtenberger LM
Gut Liver; 2013 Jan; 7(1):7-15. PubMed ID: 23423874
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol attenuates cytoprotective effects of phosphatidylcholine against bile salts.
Ikeda Y; Morita SY; Terada T
Sci Rep; 2017 Mar; 7(1):306. PubMed ID: 28331225
[TBL] [Abstract][Full Text] [Related]
17. Hepatic and renal toxicities of indomethacin acid, salt form and complexed forms with hydroxypropyl-β-cyclodextrin on Wistar rats after oral administration.
Ribeiro-Rama AC; Figueiredo IV; Veiga FJ; Castel-Branco MM; Cabrita AM; Caramona MM
Fundam Clin Pharmacol; 2011 Oct; 25(5):599-607. PubMed ID: 21077942
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of indomethacin ester prodrugs: gastrointestinal and hepatic toxicity and the hydrolytic capacity of various tissues in rats.
Ogiso T; Iwaki M; Tanino T; Nagai T; Ueda Y; Muraoka O; Tanabe G
Biol Pharm Bull; 1996 Sep; 19(9):1178-83. PubMed ID: 8889037
[TBL] [Abstract][Full Text] [Related]
19. Uric acid ameliorates indomethacin-induced enteropathy in mice through its antioxidant activity.
Yasutake Y; Tomita K; Higashiyama M; Furuhashi H; Shirakabe K; Takajo T; Maruta K; Sato H; Narimatsu K; Yoshikawa K; Okada Y; Kurihara C; Watanabe C; Komoto S; Nagao S; Matsuo H; Miura S; Hokari R
J Gastroenterol Hepatol; 2017 Nov; 32(11):1839-1845. PubMed ID: 28295549
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper-indomethacin in rats.
Bonin AM; Yáñez JA; Fukuda C; Teng XW; Dillon CT; Hambley TW; Lay PA; Davies NM
Cancer Chemother Pharmacol; 2010 Sep; 66(4):755-64. PubMed ID: 20035423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
